Orchard Therapeutics
ORTX
#6694
Rank
$0.16 B
Marketcap
$7.25
Share price
-0.68%
Change (1 day)
34.26%
Change (1 year)

Revenue for Orchard Therapeutics (ORTX)

Revenue in 2023 (TTM): $5.64 M

According to Orchard Therapeutics 's latest financial reports the company's current revenue (TTM) is $5.64 M. In 2022 the company made a revenue of $6.98 M an increase over the years 2021 revenue that were of $1.67 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Orchard Therapeutics from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$5.64 M-19.2%
2022$6.98 M317.07%
2021$1.67 M-35.45%
2020$2.59 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$0.44 M-92.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.64 M 0.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.44 B 25,416.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.50 B 8,893.09% Jersey